ORIC Pharmaceuticals, Inc.
ORIC
$5.31
-$0.10-1.85%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -30.02M | -36.31M | -34.57M | -31.96M | -25.01M |
| Total Depreciation and Amortization | 302.00K | 304.00K | 270.00K | 272.00K | 261.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.67M | 3.57M | 3.11M | 2.70M | 2.73M |
| Change in Net Operating Assets | -8.49M | 4.38M | 2.39M | 3.37M | -8.17M |
| Cash from Operations | -32.53M | -28.05M | -28.80M | -25.63M | -30.19M |
| Capital Expenditure | -387.00K | -219.00K | -418.00K | -333.00K | -218.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 22.84M | 42.87M | 23.49M | 18.61M | -61.65M |
| Cash from Investing | 22.45M | 42.66M | 23.07M | 18.28M | -61.87M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 253.00K | 575.00K | 126.00K | 816.00K | 125.20M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -242.00K | 0.00 | 0.00 | 0.00 | -168.00K |
| Cash from Financing | 11.00K | 575.00K | 126.00K | 816.00K | 125.03M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.07M | 15.18M | -5.60M | -6.53M | 32.98M |